Stock listing
REVB Stock Price, News, Filings & Events — Revelation Biosciences, Inc.
Selected listing: REVB · BOATS · USD · US
This page tracks Revelation Biosciences, Inc.'s REVB:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following REVB:BOATS. REVB:BOATS is the stock-level entry point for investors researching Revelation Biosciences, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Revelation Biosciences, Inc. (ticker: REVB) is a public company based in the United States with a market capitalization of approximately $4.14 million. The company focuses on developing innovative therapies and solutions in the biosciences sector. As a publicly traded entity, it operates within the American market, providing investors with opportunities to engage in its growth and development.

- Ticker
- REVB:BOATS
- Asset type
- Stock
- Market cap
- $4.0M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
Revelation Biosciences, Inc. REVB:BOATS stock context
This page tracks Revelation Biosciences, Inc.'s REVB:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following REVB:BOATS. REVB:BOATS is the stock-level entry point for investors researching Revelation Biosciences, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Revelation Biosciences, Inc. (ticker: REVB) is a public company based in the United States with a market capitalization of approximately $4.14 million. The company focuses on developing innovative therapies and solutions in the biosciences sector. As a publicly traded entity, it operates within the American market, providing investors with opportunities to engage in its growth and development.
Latest news from Revelation Biosciences, Inc.
Revelation Biosciences Selects Avance Clinical as CRO for Phase 2/3 TITAN Study
August 19, 2026
Revelation Biosciences, Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2026
August 6, 2026
Independent Market Assessment Results Show $94 Billion Total Addressable Market for Gemini in Stage 2 and Stage 3 Acute Kidney Injury
August 3, 2026
Revelation Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 21, 2026
Revelation Biosciences Announces Adoption of Stockholder Rights Plan
July 10, 2026
Research Revelation Biosciences, Inc.
Revelation Biosciences, Inc. investor report
Review AI stock analysis and investor report context for REVB:BOATS.
Revelation Biosciences, Inc. company profile
View the public company page for Revelation Biosciences, Inc. on 6ix.
Revelation Biosciences, Inc. news
Read company news and market updates connected to Revelation Biosciences, Inc..
Revelation Biosciences, Inc. investor events
Find investor webinars, events, and replay context for Revelation Biosciences, Inc..